Clinical Drug Assessment
In 1900, about 150,000 “mentally ill” Americans occupied hospital beds. This population had grown to 500,000 individuals by 1955, the year before chlorpromazine was introduced into psychiatric practice. With that introduction, the number of hospitalized mentally ill Americans began a steady decline, falling to below 200,000 in 1975 (Berger, 1978). As Lickey and Gordon (1983) point out, “The decline in the number of hospitalized patients has not resulted from a decrease in the rate of new hospital admissions. Rather, the new drugs have made it possible to leave the hospital after a much briefer stay” (p. 4).
KeywordsPsychiatric Diagnosis Interobserver Agreement Tardive Dyskinesia Crossover Design Drug Evaluation
Unable to display preview. Download preview PDF.